It is the first treatment of its kind to win such approval, according to the company. The product is aimed at treating canine osteosarcoma, a deadly bone cancer. It uses cells from a dog to prime ...

“He is the best dog — just a big, fun ... It turns out, he had osteosarcoma, a deadly and aggressive bone cancer in his left shoulder. The standard treatment would have been amputating his entire leg, ...

NEW YORK, March 25, 2025--(BUSINESS WIRE)--OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company ...

ECI®, the first autologous prescription product to receive USDA-CVB approval, is indicated for the treatment of canine osteosarcoma, a deadly form of bone cancer. Large and giant breed dogs ...

The decision to pursue an investigational drug for the treatment of a pet dog is often influenced by the owner's expectations for outcome, the risks associated with the conventional treatment ...